End-of-Life Health Resource Utilization for Limited English-Proficient Patients With Advanced Non-Small-Cell Lung Cancer

被引:1
|
作者
Leung, Bonnie [1 ]
Wong, Selina K. [1 ,2 ]
Ho, Cheryl [1 ,2 ]
机构
[1] BC Canc, Dept Med Oncol, Vancouver, BC, Canada
[2] Univ British Columbia, Dept Med, Vancouver, BC, Canada
关键词
POPULATION-BASED-COHORT; EMERGENCY-DEPARTMENT VISITS; PALLIATIVE CARE; LITERACY; LANGUAGE; HOMECARE; SERVICES; IMPACT;
D O I
10.1200/OP.22.00110
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE Limited English-proficient (LEP) patients with non-small-cell lung cancer (NSCLC) may receive less palliative care services and more likely to receive aggressive end-of-life (EoL) care. Goals of this retrospective cohort study are to compare access to community palliative home care (CPHC), do not resuscitate (DNR) form completion, place of death, and health resource utilization at EoL between English-proficient (EP) and LEP patients with NSCLC in Vancouver, Canada. METHODS All patients with advanced NSCLC referred in 2016 and received medical care were included. Patients were classified as LEP if seen with a medical interpreter. Descriptive statistics and univariate and multivariate analyses were used to compare the outcomes between the two groups. RESULTS One hundred eighty-six patients were referred, 66% EP. Rates of CPHC referral and DNR form completion were the same for both groups (84% and 92%, P = 1.00). LEP patients received earlier access to CPHC (15 v 10 weeks before death, P5.039). Rates of ER visits within 6months and 30 days of death were 0.89 for EP patients and 0.7 for LEP patients, P =.374, and 0.1 for EP patients and 0.13 for LEP patients, P =.244. Hospitalization rates within 6 months and 30 days of death were 1.4 for EP patients and 1.59 for LEP patients, P =.640, and 0.67 for EP patients and 0.81 for LEP patients, P =.091. EP patients were more likely to have a home death (26% v 14%), whereas LEP patients died in acute care (23% v 14%) or a tertiary palliative care unit (24% v 19%). This was not statistically significant (P =.335). LEP patients had better median overall survival (8.5 v 5.4months, P <.001), but when controlled by age, mutation, and EP status, only receipt of palliative-intent systemic therapy was statistically significant. CONCLUSION EP and LEP patients with NSCLC have similar referral rates to CPHC, DNR form completion, and EoL health resource utilization. The measured EoL variables did not demonstrate significant disparities between EP and LEP patients.
引用
收藏
页码:728 / +
页数:10
相关论文
共 50 条
  • [31] Prognosis of non-small-cell lung cancer in patients with idiopathic pulmonary fibrosis
    Han, Song Yi
    Lee, Yeon Joo
    Park, Jong Sun
    Cho, Young-Jae
    Yoon, Ho Il
    Lee, Jae-Ho
    Lee, Choon-Taek
    Chung, Jin-Haeng
    Lee, Kyung Won
    Lee, Sang Hoon
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [32] Comorbidities and relevant outcomes, commonly associated with cancer, of patients newly diagnosed with advanced non-small-cell lung cancer in Sweden
    Linden, Stephan
    Redig, Josefine
    Hernaez, Ana Banos
    Nilsson, Jonas
    Bartels, Dorthee B.
    Justo, Nahila
    EUROPEAN JOURNAL OF CANCER CARE, 2020, 29 (01)
  • [33] Multistate Healthcare Network Underutilizes Valuable End-of-Life Resources in Stage IV Non-Small Cell Lung Cancer
    Rayburn, J.
    Wilshire, C.
    Gilbert, C.
    Weerasinghe, R.
    Louie, B.
    Aye, R.
    Farivar, A.
    Vallieres, E.
    Gorden, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S358 - S358
  • [34] Is diabetes mellitus a negative prognostic factor for the treatment of advanced non-small-cell lung cancer?
    Inal, Ali
    Kaplan, M. Ali
    Kucukoner, Mehmet
    Urakci, Zuhat
    Kilinc, Faruk
    Isikdogan, Abdurrahman
    REVISTA PORTUGUESA DE PNEUMOLOGIA, 2014, 20 (02) : 62 - 68
  • [35] Retrospective studies of end-of-life resource utilization and costs in cancer care using health administrative data: A systematic review
    Langton, Julia M.
    Blanch, Bianca
    Drew, Anna K.
    Haas, Marion
    Ingham, Jane M.
    Pearson, Sallie-Anne
    PALLIATIVE MEDICINE, 2014, 28 (10) : 1167 - 1196
  • [36] Antibiotic use reduces efficacy of tyrosine kinase inhibitors in patients with advanced melanoma and non-small-cell lung cancer
    Tinsley, N.
    Zhou, C.
    Nahm, S.
    Rack, S.
    Tan, G. C. L.
    Lorigan, P.
    Blackhall, F.
    Cook, N.
    ESMO OPEN, 2022, 7 (03)
  • [37] End-of-life care of advanced chronic non-cancer patients in a medium and long term hospital
    Navarro Sanz, Ramon
    Valls Roig, Manuel
    Castellano Vela, Enrique
    MEDICINA PALIATIVA, 2011, 18 (02) : 54 - 62
  • [38] Effect of COPD on symptoms, quality of life and prognosis in patients with advanced non-small cell lung cancer
    Yi, Young-Soo
    Ban, Woo Ho
    Sohng, Kyeong-Yae
    BMC CANCER, 2018, 18
  • [39] Optimizing Treatment Risk and Benefit for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Right Treatment for the Right Patient
    Presley, Carolyn J.
    Gross, Cary P.
    Lilenbaum, Rogerio C.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (13) : 1438 - +
  • [40] Relative dose intensity of first-line chemotherapy and overall survival in patients with advanced non-small-cell lung cancer
    Crawford, Jeffrey
    Denduluri, Neelima
    Patt, Debra
    Jiao, Xiaolong
    Morrow, Phuong Khanh
    Garcia, Jacob
    Barron, Richard
    Lyman, Gary H.
    SUPPORTIVE CARE IN CANCER, 2020, 28 (02) : 925 - 932